Disseminated Zygomycosis Caused by Cunninghamella bertholletiae in Patient with Hematological Malignancy and Review of Published Case Reports

Mycopathologia

Volumn 175, Issue 1-2, 2013, Pages 99-106

  Hsieh, Tsung Ting ^a   Tseng, Hsiang Kuang ^a,b,c   Sun, Pei Lun ^a,d   Wu, Yu Hung ^a   Chen, Gon Shen ^a  

^a MACKAY MEMORIAL HOSPITAL   (Taiwan)

^b NATIONAL YANG MING UNIVERSITY   (Taiwan)

^c MACKAY MEDICAL COLLEGE   (Taiwan)

^d NATIONAL TAIWAN UNIVERSITY   (Taiwan)

Author keywords

Acute myeloid leukemia; Cunninghamella bertholletiae; Disseminated; Zygomycosis

Indexed keywords

CUNNINGHAMELLA BERTHOLLETIAE; CUNNINGHAMELLACEAE; FUNGI; MUCORALES; ZYGOMYCETES;

EID: 84872762137     PISSN: 0301486X     EISSN: None     Source Type: Journal    
DOI: 10.1007/s11046-012-9595-y     Document Type: Article

References (44)

1. Gomes MZR, Lewis RE, Kontoyiannis DP. Mucormycosis caused by unusual mucormycetes, non-Rhizopus, -Mucor, and -Lichtheimia species. Clin Microbiol Rev. 2011; 24(2): 411-45.
2. De Hoog GS, Guarro J, Gene J, Figueras MJ. Atlas of clinical fungi. 2nd ed. Utrecht: Centraalbureau voor Schimmelcultures; 2000.
3. Hsieh HM, Ju YM, Hsueh PR, Lin HY, Hu FR, Chen WL. Fungal keratitis caused by a new filamentous hyphomycete Sagenomella keratitidis. Bot Stud. 2009; 50: 331-5.
4. Diwakar A, Dewan RK, Chowdhary A, Randhawa HS, Khanna G, Gaur SN. Zygomycosis? A case report and overview of the disease in India. Mycoses. 2007; 50(4): 247-54.
5. Alvarez E, Sutton DA, Cano J, Fothergill AW, Stchigel A, Rinaldi MG, et al. Spectrum of zygomycete species identified in clinically significant specimens in the United States. J Clin Microbiol. 2009; 47(6): 1650-6.
6. Kontoyianis DP, Vartivarian S, Anaissie EJ, Samonis G, Bodey GP, Rinaldi M. Infections due to Cunninghamella bertholletiae in patients with cancer: report of three cases and review. Clin Infect Dis. 1994; 18(6): 925-8.
7. Naumann R, Kerkmann ML, Schuler U, Daniel WG, Ehninger G. Cunninghamella bertholletiae infection mimicking myocardial infarction. Clin Infect Dis. 1999; 29(6): 1580-1.
8. Darrisaw L, Hanson G, Vesole DH, Kehl SC. Cunninghamella infection post bone marrow transplant: case report and review of the literature. Bone Marrow Transplant. 2000; 25(11): 1213-6.
9. Ortín X, Escoda L, Llorente A, Rodriguez R, Martínez S, Boixadera J, et al. Cunninghamella bertholletiae infection (mucormycosis) in a patient with acute T-cell lymphoblastic leukemia. Leuk Lymphoma. 2004; 45(3): 617-20.
10. Hampson F, Ridgway E, Feeley K, Reilly J. A fatal case of disseminated zygomycosis associated with the use of blood glucose self-monitoring equipment. J Infect. 2005; 51(5): e269-72.
11. Mayayo E, Klock C, Goldani L. Thyroid involvement in disseminated zygomycosis by Cunninghamella bertholletiae: 2 cases and literature review. Int J Surg Pathol. 2011; 19(1): 75-9.
12. Robinson BE, Stark MT, Pope TL, Stewart FM, Donowitz GR. Cunninghamellabertholletiae: an unusual agent of zygomycosis. South Med J. 1990; 83(9): 1088-91.
13. Cohen-Abbo A, Bozeman PM, Patrick CC. Cunninghamella infections: review and report of two cases of Cunninghamella pneumonia in immunocompromised children. Clin Infect Dis. 1993; 17(2): 173-7.
14. Ng TT, Campbell CK, Rothera M, Houghton JB, Hughes D, Denning DW. Successful treatment of sinusitis caused by Cunninghamella bertholletiae. Clin Infect Dis. 1994; 19(2): 313-6.
15. Mazade MA, Margolin JF, Rossmann SN, Edwards MS. Survival from pulmonary infection with Cunninghamella bertholletiae: case report and review of the literature. Pediatr Infect Dis J. 1998; 17(9): 835-9.
16. Rickerts V, Bohme A, Viertel A, Behrendt G, Jacobi V, Tintelnot K, et al. Cluster of pulmonary infections caused by Cunninghamellabertholletiae in immunocompromised patients. Clin Infect Dis. 2000; 31(4): 910-3.
17. Garey KW, Pendland SL, Huynh VT, Bunch TH, Jensen GM, Pursell KJ. Cunninghamellabertholletiae infection in a bone marrow transplant patient: amphotericin lung penetration, MIC determinations, and review of the literature. Pharmacotherapy. 2001; 21(7): 855-60.
18. Sivakumar S, Mathews MS, George B. Cunninghamella pneumonia in postbone marrow transplant patient: first case report from India. Mycoses. 2005; 48(5): 360-2.
19. Paul S, Marty FM, Colson YL. Treatment of cavitary pulmonary zygomycosis with surgical resection and posaconazole. Ann Thorac Surg. 2006; 82(1): 338-40.
20. Bibashi E, Sidi V, Kotsiou M, Makrigiannaki E, Koliouskas D. Pulmonary zygomycosis caused by Cunninghamellabertholletiae in a child with acute lymphoblastic leukemia. Hippokratia. 2008; 12(1): 43-5.
21. Righi E, Giacomazzi CG, Lindstrom V, Albarello A, Soro O, Miglino M, et al. A case of Cunninghamella bertholettiae rhino-cerebral infection in a leukaemic patient and review of recent published studies. Mycopathologia. 2008; 165(6): 407-10.
22. Yagi S-I, Miyashita N, Fukuda M, Obase Y, Yoshida K, Miyauchi A, et al. Pulmonary mucormycosis (Cunninghamella bertholletiae) with cavitation diagnosed using ultra-thin fibre-optic bronchoscopy. Respirology. 2008; 13(2): 312-4.
23. Motohashi K, Ito S, Hagihara M, Maruta A, Ishigatsubo Y, Kanamori H. Cutaneous zygomycosis caused byCunninghamella bertholletiae in a patient with chronic myelogenous leukemia in blast crisis. Am J Hematol. 2009; 84(7): 447-8.
24. Garbino J, Myers C, Ambrosioni J, Gumy-Pause F. Report of a successful treatment of pulmonary Cunninghamellabertholletiae infection with liposomal amphotericin and posaconazole in a child with GvHD and review of the literature. J Pediatr Hematol Oncol. 2010; 32(2): 85-7.
25. Maloisel F, Dufour P, Waller J, Herbrecht R, Marcellin L, Koenig H, et al. Cunninghamellabertholletiae: an uncommon agent of opportunistic fungal infection. Case report and review. Nouv Rev Fr Hematol. 1991; 33(4): 311-5.
26. Zhang R, Zhang JW, Szerlip HM. Endocarditis and hemorrhagic stroke caused by Cunninghamellabertholletiae infection after kidney transplantation. Am J Kidney Dis. 2002; 40(4): 842-6.
27. Mehta N. Native aortic valve vegetative endocarditis with Cunninghamella. Eur J Echocardiogr. 2004; 5(2): 156-8.
28. Passos XS, Sales WS, Maciel PJ, Costa CR, Ferreira DM, Silva MRR. Nosocomial invasive infection caused by Cunninghamellabertholletiae: case report. Mycopathologia. 2006; 161(1): 33-5.
29. Zeilender S, Drenning D, Glauser FL, Bechard D. Fatal Cunninghamellabertholletiae infection in an immunocompetent patient. Chest. 1990; 97(6): 1482-3.
30. Chetchotisakd P, Boonma P, Sookpranee M, Pairojkul C. Rhinocerebral mucormycosis: a report of eleven cases. Southeast Asian J Trop Med Public Health. 1991; 22(2): 268-73.
31. Sato M, Gemma H, Sano T, Ono T, Atsumi E, Ito I, et al. Pulmonary mucormycosis caused by Cunninghamellabertholletiae in a non-immunocompromised woman. Nihon Kokyuki Gakkai Zasshi. 2001; 39(10): 758-62.
32. Quinio D, Karam A, Leroy JP, Moal MC, Bourbigot B, Masure O, et al. Zygomycosis caused by Cunninghamellabertholletiae in a kidney transplant recipient. Med Mycol. 2004; 42(2): 177-80.
33. Jayasuriya NSS, Tilakaratne WM, Amaratunga E, Ekanayake MKB. An unusual presentation of rhinofacial zygomycosis due to Cunninghamella sp. in an immunocompetent patient: a case report and literature review. Oral Dis. 2006; 12(1): 67-9.
34. Koyama N, Nagata M, Hagiwara K, Kanazawa M. Survival of a patient with pulmonary Cunninghamellabertholletiae infection without surgical intervention. Respirology. 2008; 13(2): 309-11.
35. Ashkenazi-Hoffnung L, Bilavsky E, Avitzur Y, Amir J. Successful treatment of cutaneous zygomycosis with intravenous amphotericin B followed by oral posaconazole in a multivisceral transplant recipient. Transplantation. 2010; 90(10): 1133-5.
36. Mukasa Y, Ichiyasu H, Akaike K, Okamoto S, Komohara Y, Kohrogi H. Autopsy case of pulmonary zygomycosis and pneumocystis pneumonia in a patient with interstitial pneumonia treated by corticosteroid therapy. Nihon Kokyuki Gakkai Zasshi. 2010; 48(11): 847-54.
37. Pimentel JD. Peritonitis due to Cunninghamellabertholletiae in a patient undergoing continuous ambulatory peritoneal dialysis. J Med Microbiol. 2006; 55(1): 115-8.
38. Cornely OA. Current controversies in treating invasive zygomycosis. J Pediatr Hematol Oncol. 2010; 32(2): 83-4.
39. Trifilio S, Singhal S, Williams S, Frankfurt O, Gordon L, Evens A, et al. Breakthrough fungal infections after allogeneic hematopoietic stem cell transplantation in patients on prophylactic voriconazole. Bone Marrow Transplant. 2007; 40(5): 451-6.
40. Almyroudis NG, Sutton DA, Fothergill AW, Rinaldi MG, Kusne S. In vitro susceptibilities of 217 clinical isolates of zygomycetes to conventional and new antifungal agents. Antimicrob Agents Chemother. 2007; 51(7): 2587-90.
41. Roden MM, Zaoutis TE, Buchanan WL, Knudsen TA, Sarkisova TA, Schaufele RL, et al. Epidemiology and outcome of zygomycosis: a review of 929 reported cases. Clin Infect Dis. 2005; 41(5): 634-53.
42. Fronek J, Hearfield H, Fassiadis N, Magrill D, Morsy M, Kessaris N. Inferior epigastric vein as an interposition graft for renal transplant artery reconstruction. Transplantation. 2010; 90(10): 1132-3.
43. Perkhofer S, Locher M, Cuenca-Estrella M, Ruchel R, Wurzner R, Dierich MP, et al. Posaconazole enhances the activity of amphotericin B against hyphae of zygomycetes in vitro. Antimicrob Agents Chemother. 2008; 52(7): 2636-8.
44. Rogers TR. Treatment of zygomycosis: current and new options. J Antimicrob Chemother. 2008; 61(Supplement 1): i35-40.